Home

Emergent BioSolutions Inc. Common Stock (EBS)

11.25
+0.14 (1.26%)

Emergent BioSolutions is a biotechnology company focused on developing and manufacturing high-quality medical countermeasures for infectious diseases, including vaccines and therapeutics

With an emphasis on public health, the company addresses a range of health threats, including those posed by bioterrorism, pandemic outbreaks, and antibiotic-resistant pathogens. Emergent works closely with government agencies and global health organizations to ensure preparedness against various health emergencies, leveraging advanced technologies and expertise in biopharmaceutical manufacturing to deliver effective solutions. Additionally, the company is involved in the production of specialty pharmaceutical products and provides contract development and manufacturing services to other organizations in the healthcare sector.

SummaryNewsPress ReleasesChartHistoricalFAQ

Frequently Asked Questions

Is Emergent BioSolutions Inc. Common Stock publicly traded?
Yes, Emergent BioSolutions Inc. Common Stock is publicly traded.
What exchange does Emergent BioSolutions Inc. Common Stock trade on?
Emergent BioSolutions Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Emergent BioSolutions Inc. Common Stock?
The ticker symbol for Emergent BioSolutions Inc. Common Stock is EBS on the New York Stock Exchange
What is the current price of Emergent BioSolutions Inc. Common Stock?
The current price of Emergent BioSolutions Inc. Common Stock is 11.25
When was Emergent BioSolutions Inc. Common Stock last traded?
The last trade of Emergent BioSolutions Inc. Common Stock was at 4:10 pm EST on January 31st, 2025
What is the market capitalization of Emergent BioSolutions Inc. Common Stock?
The market capitalization of Emergent BioSolutions Inc. Common Stock is 608.63M
How many shares of Emergent BioSolutions Inc. Common Stock are outstanding?
Emergent BioSolutions Inc. Common Stock has 54.10M shares outstanding.